Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.81 - $18.96 $292,485 - $350,760
18,500 Added 123.33%
33,500 $603,000
Q2 2024

Aug 12, 2024

SELL
$12.78 - $17.4 $95,850 - $130,499
-7,500 Reduced 33.33%
15,000 $243,000
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $240,075 - $324,675
22,500 New
22,500 $317,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $24.5B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Dcf Advisers, LLC Portfolio

Follow Dcf Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.